UiPath Inc. stocks have been trading up by 5.71 percent after upbeat automation demand news boosted investor optimism.
Key Takeaways
- Q2 FY27 revenue grew 13% year over year to $410M, with ARR up 12% to $1.94B, gross margins above 80%, and PATH profitable on both GAAP and non-GAAP operating lines.
- Management nudged FY27 revenue guidance to $1.789B–$1.794B and sees ARR at $2.065B–$2.07B, backing a mid-teens growth path with better margins.
- Citi started coverage on PATH with a Buy rating and $23 target, calling UiPath a core “control plane” for enterprise AI after the post-earnings pullback.
- RBC, BMO, and Barclays all lifted PATH price targets, flagging a beat-and-raise quarter, AI-driven deals, and stronger large-enterprise traction despite still-neutral ratings.
- The company is leaning into AI orchestration via Maestro products, a scaled PLDT deployment, and survey data positioning PATH as key to moving agentic AI from pilots to full production.
Live Update At 15:03:02 EDT: On Monday, September 14, 2026 UiPath Inc. stock [NYSE: PATH] is trending up by 5.71%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PATH has shifted from a pure story stock to a numbers-backed operator. UiPath reported Q2 FY27 revenue of $410M, up 13% year over year, with total gross margin around 83%. That is elite software territory. Annualized recurring revenue stands near $1.94B, up 12%, confirming that the subscription engine is still turning even in a shaky macro backdrop.
On the bottom line, PATH delivered about $0.07 in diluted EPS and $0.15 in non-GAAP EPS, staying profitable while pumping cash back into AI and orchestration. Operating income reached roughly $31.6M, and free cash flow for the quarter was about $29.3M, backing up that profitability with real cash.
The balance sheet is clean: minimal long-term debt, a current ratio of 2.3, and roughly $1.28B in cash and short-term investments. Valuation sits around 4.3x sales and roughly 13–14x cash flow, not nosebleed levels for an AI automation name.
More Breaking News
On the chart, PATH slid hard from the $18s pre-earnings to the mid-$13s, then bounced to close near $14.54 on 2026/09/14. Intraday, the stock based around $14.00 in premarket, then grinded higher all day, with tight 5‑minute candles between $14.50 and $14.90 into the close. For active traders, that looks like early accumulation after a washout, with $14 acting as near-term support and the mid-$15s as the first serious resistance zone.
Why Traders Are Watching PATH Right Now
PATH is sitting at the crossroads of two powerful themes: real earnings execution and the enterprise AI build‑out. UiPath cleared its Q2 FY27 bar with $410M in revenue, ahead of expectations, while keeping non-GAAP EPS at $0.15 and GAAP income positive. For a name once treated as a “grow at any cost” automation play, PATH now looks more like a disciplined AI infrastructure platform.
The guidance tweak matters. Management raised FY27 revenue to $1.789B–$1.794B and sees ARR at $2.065B–$2.07B. Those are not moonshot numbers, but they signal a business comfortable guiding to mid-teens growth while talking openly about expanding profitability. In a market that punishes missed promises, a steady “beat and raise” profile can be powerful.
Wall Street is starting to line up behind that narrative. Citi’s new Buy rating and $23 target frame UiPath as a “control plane” for enterprise AI, not just a robotic process automation vendor. That language ties PATH directly to the big AI infrastructure debate: who will sit in the middle orchestrating models, data, and workflows. At the same time, RBC, BMO, and Barclays all bumped price targets into the high teens after the quarter, acknowledging AI‑driven deal momentum and better enterprise traction even while staying neutral on ratings.
On the product side, PATH is leaning hard into orchestration. New Maestro Case and Maestro Flow products push UiPath deeper into coordinating complex, AI‑enhanced business processes rather than just automating single tasks. The PLDT win in telecom — with measurable productivity and response‑time gains — gives PATH a concrete case study it can point to when pitching new enterprise logos.
Add in the company’s global survey showing most large enterprises stuck in AI pilot mode, and PATH is positioning its platform as the missing link to get AI out of the lab. For traders, that combo of narrative, numbers, and fresh analyst support is why this pullback has everyone watching the tape.
Conclusion
For active traders, PATH’s recent action is a classic post‑earnings reset with a twist. The fundamentals improved — revenue beat, guidance inched higher, margins stayed strong — yet the stock sold off from the high teens into the low‑to‑mid $13s before stabilizing around $14–$15. That disconnect between price and progress is exactly where short‑term trading edges often show up.
UiPath now carries several tailwinds at once: a cleaner profitability profile, a balance sheet with plenty of cash and little debt, and a product roadmap centered on AI orchestration through Maestro and large‑scale deployments like PLDT. The analyst community is slowly recalibrating, raising targets on PATH into the $17–$23 range while leaving room for upside if execution keeps surprising on the high side.
From a trading mindset, the key is discipline, not narrative. As Tim Sykes likes to say, “Trade the price action, not the hype — the market doesn’t care about your opinion, only your risk management.” That dovetails with another core principle that active traders should internalize: As millionaire penny stock trader and teacher Tim Sykes, says, “You must adapt to the market; the market will not adapt to you.”. PATH’s job is to keep growing ARR and proving that enterprises will pay for an AI control plane that actually works at scale. Your job, as a trader studying PATH, is to map the key levels, respect your stops, and let the chart confirm what the story only suggests.
This article is for educational and research purposes only and is not investment advice.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:







Leave a reply